Market Cap 527.86M
Revenue (ttm) 0.00
Net Income (ttm) -49.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 536,500
Avg Vol 1,227,952
Day's Range N/A - N/A
Shares Out 31.29M
Stochastic %K 18%
Beta 0.46
Analysts Strong Sell
Price Target $53.00

Company Profile

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, Cal...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 925 7000
Address:
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States
ApexSectorMatrix
ApexSectorMatrix Dec. 27 at 8:20 AM
$LENZ Risk tolerance remains selective and tied closely to execution credibility. Margins must hold as the company navigates cost pressure. Predictability would attract a deeper institutional audience. Investors will likely insist on proof before expanding exposure.
0 · Reply
1iquid
1iquid Dec. 25 at 4:01 PM
💎 Liquid® Live Actionable Trade Asset: $LENZ Contracts: $LENZ January 15, 2027 $20 Calls Scale in: $5.24- $6.40 Scale out: $20.37-$34.92 Profit Potential : 234% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Max_Regards
Max_Regards Dec. 22 at 11:28 AM
$LENZ watch count has increased 10% on here for the company. A lot of that has happened in the last month. Anecdotal but could be an indicator of retail investor attention increasing on it.
0 · Reply
1iquid
1iquid Dec. 21 at 4:55 PM
💎 Liquid® Live Actionable Trade Asset: $LENZ Contracts: $LENZ January 15, 2027 $20 Calls Scale in: $5.51- $6.74 Scale out: $21.44-$36.75 Profit Potential : 113% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 8:18 PM
Hedge Alert Live - Protect Your Portfolio Contract: $LENZ $15.00 Put · JAN 16, 2026 Exp Entry Price: $1.16 - $1.22 Exit Price Target: $1.71 Profit Margin: +47% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
roblake29
roblake29 Dec. 19 at 7:31 PM
$LENZ My latest write-up. Critique at your leisure: https://seekingalpha.com/article/4854022-lenz-therapeutics-was-that-a-market-overreaction
2 · Reply
Max_Regards
Max_Regards Dec. 19 at 4:36 PM
$LENZ amazing how much this moves with even a little buying pressure. Hopefully we get a true positive catalyst soon.
0 · Reply
HypnoTrader
HypnoTrader Dec. 19 at 2:38 PM
$LENZ Oh yes, the misspelling investment thesis... anyways, I really don't care about this company or product. Just your anger amuses me. Keep it up.
1 · Reply
Max_Regards
Max_Regards Dec. 19 at 2:35 PM
$LENZ very telling that the market gap gets manufactured down due to shorts applying pressure and then they cannot in pre and post it moves upward. Hold strong brothers, we’re not wrong, just early!
0 · Reply
HypnoTrader
HypnoTrader Dec. 19 at 1:53 PM
$LENZ Yes! Poor Vizz into their eyes until their retinas are torn and they are blind and screaming in pain!!!
2 · Reply
Latest News on LENZ
LENZ Therapeutics: Was That A Market Overreaction?

Dec 17, 2025, 9:02 AM EST - 10 days ago

LENZ Therapeutics: Was That A Market Overreaction?


LENZ Therapeutics to Present at Upcoming Investor Conferences

Nov 25, 2025, 4:05 PM EST - 4 weeks ago

LENZ Therapeutics to Present at Upcoming Investor Conferences


LENZ Therapeutics: Undervalued Ahead Of PDUFA

Jul 29, 2025, 1:32 PM EDT - 5 months ago

LENZ Therapeutics: Undervalued Ahead Of PDUFA


LENZ Therapeutics: Presbyopia Eyedrops Look Promising

Jul 1, 2025, 4:23 PM EDT - 6 months ago

LENZ Therapeutics: Presbyopia Eyedrops Look Promising


LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:33 AM EDT - 8 months ago

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript


LENZ Therapeutics: Freedom From Reading Glasses

Apr 7, 2025, 8:00 AM EDT - 9 months ago

LENZ Therapeutics: Freedom From Reading Glasses


LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 27, 2025, 5:33 PM EDT - 9 months ago

LENZ Therapeutics Stock Is Attractive Before PDUFA


LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 8:09 PM EDT - 10 months ago

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript


LENZ Therapeutics to Host Commercial Day on April 15, 2025

Mar 3, 2025, 8:00 AM EST - 10 months ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025


LENZ Therapeutics to Participate in Upcoming Investor Conferences

Feb 24, 2025, 8:00 AM EST - 10 months ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences


Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS


LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks


ApexSectorMatrix
ApexSectorMatrix Dec. 27 at 8:20 AM
$LENZ Risk tolerance remains selective and tied closely to execution credibility. Margins must hold as the company navigates cost pressure. Predictability would attract a deeper institutional audience. Investors will likely insist on proof before expanding exposure.
0 · Reply
1iquid
1iquid Dec. 25 at 4:01 PM
💎 Liquid® Live Actionable Trade Asset: $LENZ Contracts: $LENZ January 15, 2027 $20 Calls Scale in: $5.24- $6.40 Scale out: $20.37-$34.92 Profit Potential : 234% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Max_Regards
Max_Regards Dec. 22 at 11:28 AM
$LENZ watch count has increased 10% on here for the company. A lot of that has happened in the last month. Anecdotal but could be an indicator of retail investor attention increasing on it.
0 · Reply
1iquid
1iquid Dec. 21 at 4:55 PM
💎 Liquid® Live Actionable Trade Asset: $LENZ Contracts: $LENZ January 15, 2027 $20 Calls Scale in: $5.51- $6.74 Scale out: $21.44-$36.75 Profit Potential : 113% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 8:18 PM
Hedge Alert Live - Protect Your Portfolio Contract: $LENZ $15.00 Put · JAN 16, 2026 Exp Entry Price: $1.16 - $1.22 Exit Price Target: $1.71 Profit Margin: +47% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
roblake29
roblake29 Dec. 19 at 7:31 PM
$LENZ My latest write-up. Critique at your leisure: https://seekingalpha.com/article/4854022-lenz-therapeutics-was-that-a-market-overreaction
2 · Reply
Max_Regards
Max_Regards Dec. 19 at 4:36 PM
$LENZ amazing how much this moves with even a little buying pressure. Hopefully we get a true positive catalyst soon.
0 · Reply
HypnoTrader
HypnoTrader Dec. 19 at 2:38 PM
$LENZ Oh yes, the misspelling investment thesis... anyways, I really don't care about this company or product. Just your anger amuses me. Keep it up.
1 · Reply
Max_Regards
Max_Regards Dec. 19 at 2:35 PM
$LENZ very telling that the market gap gets manufactured down due to shorts applying pressure and then they cannot in pre and post it moves upward. Hold strong brothers, we’re not wrong, just early!
0 · Reply
HypnoTrader
HypnoTrader Dec. 19 at 1:53 PM
$LENZ Yes! Poor Vizz into their eyes until their retinas are torn and they are blind and screaming in pain!!!
2 · Reply
Max_Regards
Max_Regards Dec. 19 at 1:47 PM
$LENZ make the shorts pay with their blood!
0 · Reply
ShortsHater
ShortsHater Dec. 19 at 12:59 AM
0 · Reply
H_Russell
H_Russell Dec. 18 at 8:10 PM
$LENZ thin biotech sitting in a compressed channel, catalyst plus volume is the only thing that decides which way this breaks
0 · Reply
JakeTrades1ew
JakeTrades1ew Dec. 18 at 5:05 PM
$LENZ thin biotech trapped in a tight range, first real volume spike through either edge likely decides the next big leg
0 · Reply
AngryElf
AngryElf Dec. 18 at 4:08 PM
$LENZ Just saw this commercial on tv!!!
1 · Reply
BillionerOfKing
BillionerOfKing Dec. 18 at 3:20 AM
$LENZ Current Stock Price: $16.37 Contracts to trade: $20 LENZ Dec 19 2025 Call Entry: $0.26 Exit: $0.37 ROI: 42% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Max_Regards
Max_Regards Dec. 17 at 5:59 PM
$LENZ as predicted continued downward pressure on the market is forcing shorts to consider covering their position here. Or at a minimum stops them from increasing the risk profile by shorting further.
4 · Reply
Lunr2024
Lunr2024 Dec. 16 at 11:33 PM
$LENZ Thanks to the short sellers, I completed my first trade at $16.65 per share. I would be extremely grateful if they were willing to sell me more below $15. However, considering that LENZ has not only begun distributing its products in the US market but has also signed partnership agreements with countries like Canada, South Korea, and China, my wish is unlikely to be fulfilled.
2 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 16 at 8:12 PM
Hedge Alert Live - Protect Your Portfolio Contract: $LENZ $15.00 Put · JAN 16, 2026 Exp Entry Price: $1.40 - $1.90 Exit Price Target: $2.97 Profit Margin: +112% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Max_Regards
Max_Regards Dec. 16 at 6:15 PM
$LENZ it’s still far too early to give up on this ladies and gents. 1) Direct to consumer starts in less than a month (results will be seen by March 2026) 2) 3x Analysts so far maintain buy rating and $56 price targets 3) Short sellers actively spreading fear on only down days and disappearing on major green days(shows to me they are nervous and want to spread fear when it’s already in the water) 4) approvals in motion for China, South Korea and Europe. Along with United States that’s a target demographic of 585 Million people. Capturing but only 0.2% of that market yields $1 Billion in revenue.
2 · Reply
Max_Regards
Max_Regards Dec. 16 at 6:07 PM
$LENZ Shorts benefiting from bear market but they will need to cover their shorts to mitigate risk elsewhere when their tech bubble margin calls start hitting lmao 🤣 Get ready for a wild ride.
0 · Reply
longshot45
longshot45 Dec. 16 at 6:05 PM
$LENZ Shorts appear to be in full control here. Order book not showing many buyers. I dont suppose anyone here has the weekly IQVIA data?
1 · Reply